Jade Biosciences Ownership | Who Owns Jade Biosciences?
Jade Biosciences Ownership Summary
Jade Biosciences is owned by 52.56% institutional investors, 0.04% insiders, and 47.40% retail investors. Fmr is the largest institutional shareholder, holding 22.59% of JBIO shares.
JBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Jade Biosciences | 52.56% | 0.04% | 47.40% |
| Sector | Healthcare Stocks | 232.80% | 10.63% | -143.43% |
| Industry | Biotech Stocks | 379.48% | 10.37% | -289.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 7.09M | 22.59% | $99.55M |
| Fairmount funds management | 4.55M | 14.52% | $63.98M |
| Ra capital management | 3.67M | 11.71% | $51.58M |
| Bellevue group | 3.50M | 11.17% | $49.20M |
| Vr adviser | 3.22M | 10.27% | $45.25M |
| Janus henderson group | 3.11M | 9.90% | $43.56M |
| Blackrock funding, inc. /de | 2.31M | 7.38% | $32.51M |
| Vanguard group | 2.10M | 5.29% | $32.34M |
| Baker bros. advisors lp | 1.64M | 5.23% | $23.06M |
| Versant venture management | 1.53M | 4.87% | $21.44M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant venture management | 1.53M | 15.16% | $21.44M |
| Avidity partners management lp | 1.40M | 7.73% | $34.18M |
| Fairmount funds management | 4.55M | 4.62% | $63.98M |
| Acorn capital advisors | 786.76K | 3.14% | $11.05M |
| Great point partners | 964.46K | 3.11% | $13.55M |
| Vr adviser | 3.22M | 1.69% | $45.25M |
| Samsara biocapital | 968.80K | 1.32% | $13.61M |
| Bellevue group | 3.50M | 1.17% | $49.20M |
| Foresite capital management vi | 320.00K | 0.98% | $4.50M |
| Opaleye management | 427.61K | 0.79% | $6.01M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 3.11M | 0.02% | 3.11M |
| Acorn capital advisors | 786.76K | 3.14% | 786.76K |
| Balyasny asset management | 402.49K | 0.01% | 402.49K |
| Vanguard group | 2.10M | 0.00% | 369.02K |
| Foresite capital management vi | 320.00K | 0.98% | 320.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -2.28M |
| Frazier life sciences management | - | - | -1.41M |
| Rtw investments, lp | 573.21K | 0.08% | -876.07K |
| Blackrock funding, inc. /de | 2.31M | 0.00% | -556.36K |
| Orbimed advisors | 185.01K | 0.05% | -346.15K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Janus henderson group | 3.11M | 0.02% | 3.11M | $43.56M |
| Acorn capital advisors | 786.76K | 3.14% | 786.76K | $11.05M |
| Balyasny asset management | 402.49K | 0.01% | 402.49K | $5.65M |
| Foresite capital management vi | 320.00K | 0.98% | 320.00K | $4.50M |
| Vanguard fiduciary trust | 219.50K | 0.00% | 219.50K | $3.08M |
Sold Out
| Holder | Change |
|---|---|
| Principal securities | -5.00 |
| Glenmede investment management, lp | -53.00 |
| Aster capital management (difc) | -95.00 |
| Strs ohio | -900.00 |
| Amalgamated bank | -1.45K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | -1.32% | 20,804,363 | -34.20% | 52 | 0.82% | 55 | 77.42% | 10 | -54.55% |
| Sep 30, 2025 | 29 | -59.15% | 6,448,004 | -79.55% | 22 | 0.18% | 9 | -87.14% | 14 | - |
| Jun 30, 2025 | 32 | - | 6,707,208 | - | 134,144 | - | 32 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Frohlich Tom | Chief Executive Officer | Buy | $44.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
JBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools